Canada - TSX Venture Exchange - TSX-V:NURS - CA44877L1013 - Common Stock
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 24.48M | 16.04M | 11.51M | 4.27M | 1.20M | |||
| Cost Of Goods | 17.34M | 10.35M | 6.55M | 2.26M | 560.00K | |||
| Gross Profit | 7.14M | 5.70M | 4.96M | 2.00M | 640.00K | |||
| Operating Expenses | 6.77M | 6.14M | 6.90M | 3.89M | 1.16M | |||
| Selling, General, and Administrative Expenses | 6.39M | 5.96M | 6.79M | 3.82M | 1.16M | |||
| Operating Income | 362.20K | -441.20K | -1.93M | -1.88M | -520.00K | |||
| Interest Income/Expense | 91.00K | 36.00K | -3.40K | 0.00 | 0.00 | |||
| Other Income/Expense | N/A | N/A | N/A | -10.00K | 0.00 | |||
| Non Recurring Items | N/A | N/A | 0.00 | -4.11M | 0.00 | |||
| Income Before Taxes | 453.30K | -405.20K | -1.94M | -6.00M | -520.00K | |||
| Income Tax | N/A | N/A | N/A | 0.00 | 10.00K | |||
| Net Income | 453.30K | -405.20K | -1.94M | -6.00M | -530.00K | |||
| EBITDA | 631.50K | -260.10K | -1.83M | -1.84M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.01 | -0.01 | -0.05 | -0.16 | -0.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 29.16% | 35.50% | 43.11% | 46.84% | 53.33% | |||
| Profit Margin | 1.85% | -2.53% | -16.83% | -140.52% | -44.17% | |||
| Operating Profit Margin | 1.48% | -2.75% | -16.80% | -44.03% | -43.33% | |||
All data in CAD